The QBI Seminar Series is presenting Dr. Charles L. Cywin on October 16, 2018, at 2:00 PM. Dr. Cywin joined the National Institute of Neurological Disorders and Stroke (NINDS) in 2011 in the Office of Translational Research and currently serves as the Program Director for the Blueprint Neurotherapeutics Network (BPN) http://neuroscienceblueprint.nih.gov/bpdrugs/index.htm. He is responsible for the providing project leadership and coordination for a portfolio of neuroscience drug discovery projects ranging from early discovery to Phase I trials. He is the Contract Officer Representative for our Medicinal Chemistry, DMFP, and Clinical contracts. Prior to joining NIH, he spent 17 years at Boehringer Ingelheim Pharmaceuticals where he was Director, Medicinal Chemistry and was responsible for Hit to Lead and Lead Optimization programs focused on clinical candidate selection in a number of therapeutic areas. He created the lead discovery team, the parallel synthesis group and led the efforts to identify and implement new technologies, infrastructure, and outsourcing in medicinal chemistry.

Dr. Cywin received his Bachelor’s degree in chemistry from Providence College, performed his doctoral training at Syracuse University focused on natural product synthesis where he was a University Fellow, and completed his postdoctoral fellowship with Professor E.J. Corey at Harvard focusing on asymmetric catalysis.

Talk title: "Funding Academic Neurotherapeutic Discovery"

Host: Brian Shoichet